Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Weak
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Neutral
Balance Sheet
Very Strong
Telephone
61.3.5445.5999
Address
27-33 Piper Lane East Bendigo, Victoria (VIC) 3550
Description
Apiam Animal Health Ltd. engages in the provision of veterinary products and services to the production of animals, companion animals, and equine. It operates through the following segments: Dairy and Mixed, Feedlots, and Pigs. The company was founded by Christopher Irwin Richards in 1998 and is headquartered in East Bendigo, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.32 - 0.56
Trade Value (12mth)
AU$23,187.00
1 week
-2.6%
1 month
1.35%
YTD
-6.25%
1 year
4.17%
All time high
1.85
EPS 3 yr Growth
-32.80%
EBITDA Margin
12.00%
Operating Cashflow
$19m
Free Cash Flow Return
8.90%
ROIC
2.30%
Interest Coverage
4.40
Quick Ratio
0.50
Shares on Issue (Fully Dilluted)
181m
HALO Sector
Healthcare
Next Company Report Date
01-Sep-25
Ex Dividend Date (est.)
03-Mar-25
Next Dividend Pay Date (est.)
28-Mar-25
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
28 March 25 |
Application for quotation of securities - AHX
×
Application for quotation of securities - AHX |
28 March 25 |
Change of Director's Interest Notice 3 Directors
×
Change of Director's Interest Notice 3 Directors |
25 March 25 |
Change of Director's Interest Notice - C Richards
×
Change of Director's Interest Notice - C Richards |
19 March 25 |
Update - Dividend/Distribution - AHX
×
Update - Dividend/Distribution - AHX |
26 February 25 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
26 February 25 |
Dividend/Distribution - AHX
×
Dividend/Distribution - AHX |
26 February 25 |
H1 FY25 Results Announcement
×
H1 FY25 Results Announcement |
26 February 25 |
H1 FY25 Results Presentation
×
H1 FY25 Results Presentation |
26 February 25 |
Impairment of underperforming NSW Equine Business
×
Impairment of underperforming NSW Equine Business |
19 February 25 |
H1 FY25 Reporting Date and Investor Webinar Notification
×
H1 FY25 Reporting Date and Investor Webinar Notification |
24 January 25 |
Release of securities from voluntary escrow
×
Release of securities from voluntary escrow |
08 January 25 |
Notification of cessation of securities - AHX
×
Notification of cessation of securities - AHX |
03 December 24 |
Notification regarding unquoted securities - AHX
×
Notification regarding unquoted securities - AHX |
03 December 24 |
Change of Director's Interest Notice C Richards
×
Change of Director's Interest Notice C Richards |
02 December 24 |
Release of shares from escrow
×
Release of shares from escrow |
22 November 24 |
Final Director's Interest Notice J Tennent
×
Final Director's Interest Notice J Tennent |
21 November 24 |
Chair's and MD's Address to Shareholders
×
Chair's and MD's Address to Shareholders |
21 November 24 |
MD presentation to the AGM
×
MD presentation to the AGM |
21 November 24 |
Results of Meeting
×
Results of Meeting |
12 November 24 |
Notification regarding unquoted securities - AHX
×
Notification regarding unquoted securities - AHX |
01 November 24 |
Notification of cessation of securities - AHX
×
Notification of cessation of securities - AHX |
01 November 24 |
Change of Director's Interest Notice- C Richards
×
Change of Director's Interest Notice- C Richards |
25 October 24 |
Release of securities from voluntary escrow
×
Release of securities from voluntary escrow |
21 October 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
10 October 24 |
Apiam rejects non-binding indicative offer
×
Apiam rejects non-binding indicative offer |
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.